Jonathan Smith369
commented on
$Cardiol Therapeutics(CRDL.US$
NEWS
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
Cardiol Therapeutics presented its Phase II ARCHER trial at the World Congress on Acute Heart Failure 2024. The trial is evaluating CardiolRx™ in patients with acute myocarditis. The presentation included the trial design, rationale, and baseline data on the first 50 patients randomized. The ARCHER trial has exceeded 85% of target enrollment, with ...
NEWS
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
Cardiol Therapeutics presented its Phase II ARCHER trial at the World Congress on Acute Heart Failure 2024. The trial is evaluating CardiolRx™ in patients with acute myocarditis. The presentation included the trial design, rationale, and baseline data on the first 50 patients randomized. The ARCHER trial has exceeded 85% of target enrollment, with ...
1
1
Jonathan Smith369
voted
Happy Friday, mooers! Welcome back to Weekly Buzz, where we review the news, performance, and community sentiment of the top ten buzzing stocks on moomoo based on search and message volumes! Comment below to answer the Weekly Topic question for a chance to win an award!
Make Your Choice
Weekly Buzz
This week was all about meme stocks. The market screamed, "We are so back," at the start of the week, after 'Roaring Kitty,' short squeezing enthusiast and financia...
Make Your Choice
Weekly Buzz
This week was all about meme stocks. The market screamed, "We are so back," at the start of the week, after 'Roaring Kitty,' short squeezing enthusiast and financia...
+11
30
21
Jonathan Smith369 : When this gonna jump thooo